Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats

Biotech Histochem. 2023 Nov;98(5):314-325. doi: 10.1080/10520295.2023.2187460. Epub 2023 Mar 22.

Abstract

Diabetes mellitus (DM) is a chronic disease at all ages including childhood and puberty. Failure to treat DM can cause retinopathy, nephropathy and neuropathy. Endocrine and metabolic changes during the pubertal period complicate management of DM. Noopept is a cognitive enhancer that exhibits antidiabetic properties. We investigated the effect of noopept on the histopathology of the cornea, retina, kidney and pancreas in pubertal diabetic rats. We allocated 60 prepubertal male rats randomly into six groups of 10: untreated control (C), DM control (DC), noopept control (NC), DM + noopept (D + N), DM + insulin (D + I) and DM + insulin + noopept (D + I + N). DM was induced by streptozotocin in the DC, D + N, D + I and D + I + N groups. Noopept was administered to the NC, D + N and D + I + N groups; insulin was administered to the D + I and D + I + N groups for 14 days. On day 18 of the experiment, animals were sacrificed and eyes, kidneys and pancreata were excised for histological investigation. Renal tubule diameter and corneal and retinal thickness were increased significantly in DC groups compared to the control group. The D + I, D + N and D + I + N groups exhibited fewer DM induced pathological changes than the DC group. The D + I + N group exhibited no significant differences in renal tubule diameter and corneal and retinal thickness compared to the DC group. Our findings suggest that noopept is protective against DM end organ complications in streptozotocin induced diabetic pubertal rats.

Keywords: Cornea; diabetes mellitus; histopathology; kidney; noopept; pancreas; pubertal period; rats; retina.

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental* / metabolism
  • Insulin / metabolism
  • Insulin / pharmacology
  • Kidney
  • Male
  • Pancreas
  • Rats
  • Sexual Maturation
  • Streptozocin / pharmacology

Substances

  • ethyl phenylacetyl-Pro-Gly
  • Streptozocin
  • Insulin